Circulating miR-146a predicts glucocorticoid response in thyroid eye disease

OBJECTIVE: Thyroid eye disease (TED) is an immune-mediated disorder of the eye. Intravenous glucocorticoid (GC) is the first-line treatment for patients with active moderate-to-severe TED. However, the response rate is between 50% and 80%. There are still no simple and reliable markers of responsive...

Descripción completa

Detalles Bibliográficos
Autores principales: Manso, Jacopo, Censi, Simona, Clausi, Cristina, Piva, Ilaria, Zhu, Yi Hang, Mondin, Alberto, Pedron, Maria Chiara, Barollo, Susi, Bertazza, Loris, Midena, Giulia, Parrozzani, Raffaele, Mian, Caterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563606/
https://www.ncbi.nlm.nih.gov/pubmed/37606076
http://dx.doi.org/10.1530/ETJ-23-0083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563606/
https://www.ncbi.nlm.nih.gov/pubmed/37606076
http://dx.doi.org/10.1530/ETJ-23-0083

Ejemplares similares